4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-040433
Chairman and CEO bought 3,216 shares at an average $1.61 ($5,180)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-06-10 | Purchase | +1,000 | $1.65 | $1,650 | 10,758,915 | D |
| Niihara Yutaka Chairman and CEO | 2021-06-11 | Purchase | +800 | $1.58 | $1,264 | 10,759,715 | D |
| Niihara Yutaka Chairman and CEO | 2021-06-14 | Purchase | +1,416 | $1.60 | $2,266 | 10,761,131 | D |
| Open-market purchases · 3,216 sh · avg $1.61 · $5,180 | |||||||
Loading xslF345X03/doc4.xml…